We've done great things in the past.
Today, we're doing great things for the future.

Merck and Schering-Plough merged in 2009 to create a new company, known as MSD in New Zealand, Australia, Asia and Europe and Merck in the USA and Canada. Today, we are the second-largest pharmaceutical company in the world. We also are a global leader in consumer products and animal care.

Both MSD and Schering-Plough have a long and rich history of working to improve people's health and well-being. Through the years, our researchers have helped to find new ways to treat and prevent illness - from the discovery of vitamin B1, to the first measles vaccine, to cold remedies and antacids, to the first statins to treat high cholesterol. Our scientists have also helped develop many products to improve animal health, including vaccines and antibiotics.

While we are proud of our past, we are enthusiastic about the future of our combined company and we are excited to help create a healthier, brighter future for people around the world.

Beginnings in New Zealand

MSD New Zealand began trading in Wellington, in 1962. Initially MSD New Zealand marketed both animal health and human medicines, with its animal range out-selling the human range.

Today MSD New Zealand's focus is on clinical research and marketing a wide range of prescription only and consumer medicines for human health conditions. The animal health products are marketed worldwide through MSD Animal Health.

The Name "Merck"

Merck & Co., Inc. (based in New Jersey, USA) and Merck KGaA (the former E. Merck and headquartered in Darmstadt, Germany) are both active companies and therefore some confusion over the name "Merck" still exists. The companies have agreed that Merck & Co., Inc. will use the name Merck in the US and Canada and in the rest of the world, it is known as MSD (Merck Sharp & Dohme). Merck KGaA uses the name EMD in the United States and uses the name Merck in the rest of the world.